Seneca Biopharma OverviewSeneca Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for SNCA.
Quarterly EBIT
-$16.25M
↓ 699.4% YoY
As of Dec 31, 2020
Annual EBIT (TTM)
-$20.05M
↓ 258.57% YoY
Trailing 12 months ending Dec 31, 2020
Seneca Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for SNCA.
As of Dec 31, 2020
Trailing 12 months ending Dec 31, 2020